bioAffinity Technologies, Inc. (BIAF)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.66
+20.21%
Mkt Cap $4.77M
No analyst coverage available
We don't have analyst ratings or price target data for bioAffinity Technologies, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.